Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

April 9, 2026

Hope on the Horizon for ADTKD Patients

ADTKD is the second most common genetic kidney disease after Polycystic Kidney Disease, affecting an estimated 75,000–100,000 in

April 8, 2026

TUCSON, Ariz., April 8, 2026 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator has awarded...

April 8, 2026

As precision medicine advances, approaches to benefit–risk must evolve beyond traditional models designed...

April 1, 2026

At a recent public workshop co-convened by the Duke-Margolis Institute for Health Policy...

March 31, 2026

Welcome to the Rare/Orphan and Pediatric Disease Programs quarterly newsletter. In between major announcements...

March 31, 2026

As we close the first quarter of the year, we are energized by the opportunities ahead to further strengthen collaboration...

March 30, 2026

This workshop took place virtually on March 30, 2026, at 2:00 PM ET and explored how emerging kidney biomarkers...

March 27, 2026

March is National Kidney Month, making it an ideal time to highlight the progress and collaborations helping advance kidney health

March 26, 2026

FDA’s plausible mechanism framework aims to accelerate and expand drug development for patients...

March 26, 2026

C-Path today announced the launch of One to Millions, a global, multi-stakeholder public-private initiative...